Published on 5 Jan 2024 on GuruFocus.com via Yahoo Finance
Bicycle Therapeutics PLC CEO Kevin Lee Sells 8,703 Shares
On January 3, 2024, CEO Kevin Lee sold 8,703 shares of Bicycle Therapeutics PLC (NASDAQ:BCYC), according to a recent SEC Filing. This transaction is part of a series of insider sales over the past year, with the insider having sold a total of 13,157 shares and having made no purchases of the company's stock during the same period.
Warning! GuruFocus has detected 6 Warning Signs with BCYC.
Bicycle Therapeutics PLC is a biotechnology company focused on developing a novel class of medicines referred to as Bicycles. These synthetic short peptides are designed to combine the attributes of antibodies, small molecules, and peptides to create therapeutics with high specificity and affinity for disease targets.